OP0047 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 78.2-78 ◽  
Author(s):  
R. van Vollenhoven ◽  
C. Aranow ◽  
B. Rovin ◽  
C. Wagner ◽  
B. Zhou ◽  
...  
Keyword(s):  
Lupus Nephritis ◽  
Phase 2 ◽  
Proof Of Concept ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Concept Study ◽  
Active Lupus Nephritis ◽  
Active Lupus

scholarly journals BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS

2021 ◽  
Author(s):  
Mittermayer Barreto Santiago ◽  
Richard Furie ◽  
Brad Rovin ◽  
Frédéric Houssiau ◽  
Zahir Amoura ◽  
...  
Keyword(s):  
Lupus Nephritis ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Active Lupus Nephritis ◽  
Active Lupus
Sign in / Sign up

Export Citation Format

Share Document